Navigation Links
Mersana's Second Development Candidate, XMT-1107, Shows Superior Pharmacokinetics and Anti-Tumor Activity in Studies Presented at American Association of Cancer Research Meeting
Date:4/19/2009

d compound, XMT-1107, is expected to move into the clinic by early 2010. Mersana's preclinical pipeline also includes proprietary targeting moieties employed with conjugates for delivery of siRNA and anti-cancer agents.

The key component of Mersana's platform is Fleximer(R), a novel, biodegradable and bio-inert polymer that can be chemically linked to small molecules and biologics. Fleximer(R) technology improves the therapeutic index of existing compounds by uniquely combining biodegradability with "biological stealth" properties, making Fleximer(R) materials and their conjugates long-circulating and non-immunotoxic. Fleximer(R) molecules are characterized by solubility in water, with stability in common manufacturing procedures. Mersana's investors include Fidelity Biosciences, ProQuest Investments, Rho Ventures, Harris & Harris Group and PureTech Ventures. For more information, visit www.mersana.com.

Fleximer and Mersana(R) are trademarks of Mersana Therapeutics, Inc.


'/>"/>
SOURCE Mersana Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Secondhand Smoke Quickly Affects Blood Vessels
2. Every 30 Seconds an African Child Dies from Malaria; Education Key to Prevention
3. Rochester Medical Announces Second Quarter 2009 Earnings Conference Call April 30, 2009
4. Valensa Completes Second Expansion of Astaxanthin Capacity
5. Success of Colorful School Supply Collection Inspired by Leukemia Patient Kicks off Second Year
6. Metro Parents Second Annual Living With Autism Workshop Features Local Experts Who Are Intimately Involved in Improving the Lives of These Special Children
7. Equinox Fitness Clubs Continues National Expansion with the Opening of its Second Boston Location
8. Second European Radiosurgery Workshop Yields Record Attendance
9. Secondhand Smoke Affecting Millions of New Yorkers
10. Hillenbrand Expects to Report Second-Quarter Net Revenue of $170.8 Million and Revises 2009 Guidance
11. MoleSafe USA Opens Second Location in Albuquerque, New Mexico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Wellcome Trust Sanger Institute announce the first comprehensive analyses ... by mutations in the DNA of cancer cells which ... a malignant melanoma and a lung cancer, reveal for ... genomes of two cancers. , Lung cancer causes around ... associated with smoking. The number of mutations found suggest ...
(Date:12/16/2009)... commonly found in fatty fish and algae help ... by the American Psychological Association. The finding connects ... people with schizophrenia; bipolar, obsessive-compulsive, and attention-deficit hyperactivity ... nervous system. , The study, reported in ... evidence that fish is brain food. The key ...
(Date:12/16/2009)... animals, they cut bleeding time in half, but use in ... News) -- Hoping to improve on nature, researchers have built ... to be used in trauma or other cases where blood ... core, with material that is used in degradable stitches, which ... of biomedical engineering at Case Western Reserve University, and lead ...
(Date:12/16/2009)... Stress Reduction Therapy or NSRTSM is found very effective in ... as allergies, asthma, migraines, chronic fatigue and a wide array ... country are using this holistic therapy including over 50 branded ... ... Minneapolis, MN (Vocus) December 14, 2009 -- BioVeda Health ...
(Date:12/16/2009)... percent of children are uninsured, government report finds , , ... six months of this year, 45.4 million Americans of ... -- had no health insurance, according to new National ... 58.4 million (19.4 percent) people of all ages had ... prior to the interview, and 31.9 million (10.6 percent) ...
Breaking Medicine News(10 mins):Health News:Lung cancer and melanoma laid bare 2Health News:Lung cancer and melanoma laid bare 3Health News:Lung cancer and melanoma laid bare 4Health News:Lung cancer and melanoma laid bare 5Health News:Lung cancer and melanoma laid bare 6Health News:New study links DHA type of omega-3 to better nervous-system function 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 5Health News:Over 45 Million Americans Now Lack Health Insurance 2
... Still Needed to Prepare,for Future Disasters, WASHINGTON, Oct. ... has met the expected costs of the California,wildfires but ... ensure,it can respond to the next disaster just as ... When the wildfires struck, the Red Cross opened 26 ...
... ER staff should focus on those with first-ever attack, ... Oct. 29 (HealthDay News) -- Immediate CT brain scans ... with seizures to help doctors determine the right kind ... the American Academy of Neurology. , The guideline authors ...
... Technology and Intellectual Property, has received a 2007 Deal ... U.S.A. and Canada. , The award stems from an ... Chicago and the Mayo Clinic. The deal licensed the ... side effects from a standard first-line treatment for advanced ...
... CINCINNATI, Oct. 29 CH Mack, Inc., a ... human services, managed care and,acute care organizations, announced ... Developmental Disabilities (MR/DD) has chosen its Q,Continuum System. ... Continuum of Case,Management software solution, contains a complete ...
... WASHINGTON, Oct. 29 It,s been six years,since ... But if the,D.C. region were attacked again, are ... The medical leadership of the prestigious Washington Hospital,Center ... at the,Willard InterContinental Hotel with "ARE WE READY?" ...
... (Nasdaq: MEMY ) announced today that James Sulat,President ... following,upcoming investor conferences: Acumen BioFin Rodman & Renshaw ... 10:15 a.m. Eastern Time at The New York Palace,Hotel ... Annual Healthcare Conference on Tuesday,November 6, 2007 at 2:30 ...
Other Medicine News:Health News:Generous Donors Allow Red Cross to Respond Swiftly and Effectively to California Wildfires 2Health News:Generous Donors Allow Red Cross to Respond Swiftly and Effectively to California Wildfires 3Health News:Certain Seizure Patients Need Emergency CT Scan 2Health News:Gene screen patent leads to 'Deal of Distinction' 2Health News:Columbiana County Board of MR/DD Chooses Q Continuum(TM) System 2Health News:Columbiana County Board of MR/DD Chooses Q Continuum(TM) System 3Health News:Are We Ready? Washington Hospital Center Sets Precedents in Preparedness for 9/11-Style Attacks 2
(Date:12/16/2009)... NEW YORK, December 16 ... the publication of GFT505 (80 mg/day),data ... 50 internationally,recognized expert scientists and clinicians ... the continuing role of generic lipid-modifying,treatments, ... which is commonly observed in patients ...
(Date:12/16/2009)... RealMed has been ranked the ... 2009 Top 20 Best in KLAS ... RealMed is a dynamic revenue cycle management ... between healthcare providers and all ... specializing in vendor performance measurement in the ...
(Date:12/16/2009)... WALTHAM, Mass., Dec. 16 According to ... medical technology market intelligence, health care reforms in ... stent market in 2009, and will continue to ... new Asia Pacific Markets for Interventional Cardiology ... by the Chinese government will allow the Chinese ...
Breaking Medicine Technology:International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 3RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 2RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 3Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 2Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 3Critical link in cell death pathway revealed 52451 1Critical link in cell death pathway revealed 52451 2House Democrats Health Plan Contains Words of Coercion Not Choice Text Analysis Shows 52446 1House Democrats Health Plan Contains Words of Coercion Not Choice Text Analysis Shows 52446 2Many Young Adults Uninformed About Vaccines 52443 1Many Young Adults Uninformed About Vaccines 52443 2Many Young Adults Uninformed About Vaccines 52443 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: